98%
921
2 minutes
20
Background: In the United States, community overdose education and naloxone distribution (OEND) programs have demonstrated efficacy in reducing opioid-related mortality. OEND programs have expanded across San Diego County, California, but differential naloxone accessibility among people who use drugs (PWUD) has not been assessed. We examined factors that shape individual naloxone accessibility in San Diego.
Methods: We employed a convergent parallel mixed methods design using surveys (n = 194) and qualitative interviews (n = 20). Ordinal logistic regression examined factors associated with individual naloxone accessibility (i.e., the frequency with which participants could access naloxone within five minutes, categorized as never, sometimes, or always). Qualitative interviews explored participant perceptions of naloxone accessibility and whether and how they maintained naloxone. We organized multilevel findings into a modified social-ecological model.
Results: In quantitative and qualitative samples, participants were majority male (72 % and 70 % respectively), non-White race/ethnicity (55 % and 75 %), with an average age around 42 years. In the quantitative sample, 24 % never had personally accessible naloxone, 52 % sometimes did, and 24 % always did. Factors independently associated with individual naloxone accessibility were female gender (Adjusted Odds Ratio [AdjOR]: 2.51, 95 % Confidence Interval [CI]: 1.31-4.85), monthly income <$500 (AdjOR: 0.42, 95 %CI:0.19, 0.90), witnessing an overdose (AdjOR: 3.51, 95 %CI:1.67-7.55), and knowing where to get free naloxone (AdjOR: 3.44, 95 %CI: 1.79-6.75). Qualitative data suggested that naloxone was generally easy to acquire in San Diego due to community harm reduction outreach and mutual aid among peers, albeit community barriers including distance to harm reduction providers and frequent relocation/displacement for those experiencing homelessness. Individual attitudes toward overdose risk, naloxone, and community responsibility contributed to varied individual naloxone accessibility.
Conclusions: This study highlights multilevel factors influencing individual naloxone accessibility among people who use drugs in San Diego, emphasizing the importance of harm reduction outreach and peer-to-peer support. We identified opportunities for interventions that address both individual attitudes and community-level barriers to improve naloxone accessibility.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11789787 | PMC |
http://dx.doi.org/10.1016/j.drugpo.2024.104577 | DOI Listing |
J Sch Health
September 2025
Brigham and Women's Hospital, Boston, Massachusetts, USA.
Background: The opioid crisis continues to claim lives across the United States, which has led to increased attention toward harm reduction strategies as methods for addressing this public health issue. Specifically, naloxone, an opioid overdose reversal drug, became available over-the-counter in 2023, greatly improving its accessibility. However, despite this progress, general awareness about how to use naloxone remains limited, especially among youth who are being increasingly impacted by the opioid epidemic.
View Article and Find Full Text PDFHealth Aff Sch
August 2025
Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Introduction: Employers play a critical role in addressing the opioid crisis in the United States, so the federal government created the Recovery-Ready Workplace (RRW) framework, which suggests employer action in 4 areas: prevention and risk reduction, education, employment, and treatment.
Methods: This study examines employees' views of RRW-related actions taken by their employers to address opioid misuse, using a national survey of 1010 U.S.
Health Aff (Millwood)
September 2025
Carlton M. Kelly, Northwestern University.
Racial and ethnic disparities in opioid overdose deaths in the US have widened in recent years, potentially driven by inequitable access to naloxone. This study evaluated engagement across the naloxone care cascade, a framework encompassing awareness, access, training, possession, and use of naloxone. Using a nationally representative US sample, we analyzed data from 57,719 adults who completed the 2024 Survey of Non-Medical Use of Prescription Drugs to characterize differences by race and ethnicity in the degree of contact with any component of the naloxone care cascade.
View Article and Find Full Text PDFHealth Aff (Millwood)
September 2025
Pooja Lagisetty, University of Michigan, Ann Arbor, Michigan.
A central challenge in the opioid crisis in the US has been the underuse of lifesaving treatment and harm reduction programs. Conventional explanations focus on limited access to care when services are not convenient, affordable, or timely. However, these factors exist downstream from other fundamental causes of low utilization.
View Article and Find Full Text PDFSubst Use Misuse
September 2025
National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland, USA.
Introduction: Despite recent declines, the U.S. opioid overdose crisis persists.
View Article and Find Full Text PDF